Reveal HealthTech, a healthcare-focused AI company, has raised $7.2 million in Series A funding led by Leo Capital, with participation from Sanos Capital. The round marks a major milestone for the two-year-old company, founded in 2023 and incubated by W Health Ventures and 2070 Health.
Positioning itself as a “healthcare AI specialist,” Reveal HealthTech works with the US healthcare and life sciences organisations to identify high-value challenges and design safe, clinically relevant AI systems.
“Every year, across hundreds of thousands of patient touchpoints, we’ve seen the profound impact that compassion and intelligence can have when woven into care,” said Dr Sumir Sahgal, founder and chief medical officer of Essen Health Care, a New York-based healthcare delivery network. “With Reveal, that vision is becoming reality. By acting on data in real-time, we’re not only improving patient experiences but also easing the burden on clinicians.”
The company’s solutions include BioCanvas, which supports multimodal AI use cases like clinical trial recruitment, and Prism AI, a platform for building intelligent agents to automate healthcare workflows.
In one recent deployment for a $40 billion U.S. medical device company, Reveal integrated patient data to boost adherence and created a reusable blueprint for other healthcare clients.
“Our mission is simple but bold,” said Sanchit Mullick, founder of Reveal HealthTech. “We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.”
Backers Leo Capital and Sanos Capital emphasised Reveal’s ability to deliver tailored AI solutions with measurable outcomes. “Their superpower lies in crafting solutions that demonstrate time-bound, business goodness to clients. We’re very excited to support the team in its next phase of growth,” Rajul Garg, partner at Leo Capital and co-founder of Pine Labs and GlobalLogic, said.
The fresh funding will fuel product expansion, strengthen Reveal’s sales network, and extend its presence across US healthcare and life sciences. Reveal will also join the Cipher Collective, an AI-powered partner network for next-generation healthcare technologies.
